BOTHELL, Wash., Aug. 6 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK - News) will host a Webinar to discuss the Company's novel approach for the development of small interfering RNA (siRNA) therapeutics for treatment of influenza. Details follow:
